Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Goed antibioticagebruik: belemmeringen en kansen
okt 2019 | Antibioticaresistentie, Bacteriële infecties